Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1995 Mar;79(3):264–266. doi: 10.1136/bjo.79.3.264

Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid.

M J Elder 1, S Lightman 1, J K Dart 1
PMCID: PMC505076  PMID: 7703207

Abstract

AIMS/BACKGROUND--Ocular cicatricial pemphigoid (OCP) can present with severe conjunctival inflammation that requires systemic immunosuppression to avoid serious ocular morbidity. This study aimed to assess the clinical response to cyclophosphamide and short term, high dose prednisolone in this group of patients. METHODS--A prospective, unmasked study assessed patients presenting with either 'severe' ocular inflammation (n = 4) or 'marked' or 'severe' ocular inflammation that had failed to respond to other systemic immunosuppression (n = 6). Nineteen inflamed eyes of 10 consecutive patients were enrolled. RESULTS--The ocular inflammation resolved in 15 eyes in a mean time of 2.4 months. Two eyes perforated despite treatment and one patient was unable to tolerate the medication. Progressive cicatrisation occurred in 21%. CONCLUSION--Cyclophosphamide and short term, high dose prednisolone are effective in severe inflammation caused by OCP but may not completely prevent cicatrisation.

Full text

PDF
265

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berkson B. M., Lome L. G., Shapiro I. Severe cystitis induced by cyclophosphamide. Role of surgical management. JAMA. 1973 Aug 6;225(6):605–606. [PubMed] [Google Scholar]
  2. Bernauer W., Wright P., Dart J. K., Leonard J. N., Lightman S. The conjunctiva in acute and chronic mucous membrane pemphigoid. An immunohistochemical analysis. Ophthalmology. 1993 Mar;100(3):339–346. doi: 10.1016/s0161-6420(93)31644-1. [DOI] [PubMed] [Google Scholar]
  3. Boitard C., Bach J. F. Long-term complications of conventional immunosuppressive treatment. Adv Nephrol Necker Hosp. 1989;18:335–354. [PubMed] [Google Scholar]
  4. Dantzig P. I. Immunosuppressive and cytotoxic drugs in dermatology. Arch Dermatol. 1974 Sep;110(3):393–406. [PubMed] [Google Scholar]
  5. Foster C. S. Cicatricial pemphigoid. Trans Am Ophthalmol Soc. 1986;84:527–663. [PMC free article] [PubMed] [Google Scholar]
  6. Foster C. S., Wilson L. A., Ekins M. B. Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Ophthalmology. 1982 Apr;89(4):340–353. doi: 10.1016/s0161-6420(82)34791-0. [DOI] [PubMed] [Google Scholar]
  7. Hardy K. M., Perry H. O., Pingree G. C., Kirby T. J., Jr Benign mucous membrane pemphigoid. Arch Dermatol. 1971 Nov;104(5):467–475. [PubMed] [Google Scholar]
  8. Mondino B. J., Brown S. I. Immunosuppressive therapy in ocular cicatricial pemphigoid. Am J Ophthalmol. 1983 Oct;96(4):453–459. doi: 10.1016/s0002-9394(14)77908-5. [DOI] [PubMed] [Google Scholar]
  9. Mondino B. J., Brown S. I., Lempert S., Jenkins M. S. The acute manifestations of ocular cicatricial pemphigoid: diagnosis and treatment. Ophthalmology. 1979 Apr;86(4):543–555. doi: 10.1016/s0161-6420(79)35486-0. [DOI] [PubMed] [Google Scholar]
  10. Mondino B. J., Brown S. I. Ocular cicatricial pemphigoid. Ophthalmology. 1981 Feb;88(2):95–100. doi: 10.1016/s0161-6420(81)35069-6. [DOI] [PubMed] [Google Scholar]
  11. Mondino B. J., Brown S. I., Rabin B. S. Autoimmune phenomena of the external eye. Ophthalmology. 1978 Aug;85(8):801–817. doi: 10.1016/s0161-6420(78)35618-9. [DOI] [PubMed] [Google Scholar]
  12. Mondino B. J. Cicatricial pemphigoid and erythema multiforme. Ophthalmology. 1990 Jul;97(7):939–952. doi: 10.1016/s0161-6420(90)32479-x. [DOI] [PubMed] [Google Scholar]
  13. Mondino B. J., Ross A. N., Rabin B. S., Brown S. I. Autoimmune phenomena in ocular cicatricial pemphigoid. Am J Ophthalmol. 1977 Apr;83(4):443–450. doi: 10.1016/0002-9394(77)90546-3. [DOI] [PubMed] [Google Scholar]
  14. Person J. R., Rogers R. S., 3rd Bullous and cicatricial pemphigoid. Clinical, histopathologic, and immunopathologic correlations. Mayo Clin Proc. 1977 Jan;52(1):54–66. [PubMed] [Google Scholar]
  15. Rogers R. S., 3rd, Seehafer J. R., Perry H. O. Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone. J Am Acad Dermatol. 1982 Feb;6(2):215–223. doi: 10.1016/s0190-9622(82)70014-3. [DOI] [PubMed] [Google Scholar]
  16. Sacks E. H., Jakobiec F. A., Wieczorek R., Donnenfeld E., Perry H., Knowles D. M., Jr Immunophenotypic analysis of the inflammatory infiltrate in ocular cicatricial pemphigoid. Further evidence for a T cell-mediated disease. Ophthalmology. 1989 Feb;96(2):236–243. doi: 10.1016/s0161-6420(89)32922-8. [DOI] [PubMed] [Google Scholar]
  17. Schwab I. R., Linberg J. V., Gioia V. M., Benson W. H., Chao G. M. Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medications. Ophthalmology. 1992 Feb;99(2):197–202. doi: 10.1016/s0161-6420(92)32001-9. [DOI] [PubMed] [Google Scholar]
  18. Tauber J., Sainz de la Maza M., Foster C. S. Systemic chemotherapy for ocular cicatricial pemphigoid. Cornea. 1991 May;10(3):185–195. doi: 10.1097/00003226-199105000-00001. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES